Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.thechemopharmalaboratoriesltd.com | |
Market Cap | 5.66 Cr. | |
Enterprise Value(EV) | 0.07 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.23 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 16.88 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.80 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 78.33 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.48 | Calculated using Price: 37.70 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.15 Cr. | 1,500,000 Shares |
FaceValue | 10 | |
Company Profile | ||
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues. |
1 Day |
|
+4.87% |
1 Week |
|
-3.33% |
1 Month |
|
+3.01% |
3 Month |
|
-1.95% |
6 Month |
|
-0.79% |
1 Year |
|
-14.32% |
2 Year |
|
+41.20% |
5 Year |
|
-13.33% |
10 Year |
|
+93.83% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 5.10 | 5.61 | 4.15 | 60.99 | 1.00 | 2.02 | 3.94 | 2.30 | 4.97 | |
Return on Capital Employed (%) | 6.22 | 7.52 | 5.96 | 68.41 | 7.54 | 2.50 | 4.69 | 2.86 | 3.24 | |
Return on Assets (%) | 4.79 | 5.20 | 3.90 | 57.64 | 0.96 | 2.00 | 3.88 | 2.27 | 4.99 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Curr. Liab. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 | |
Non Curr. Assets | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 0 | 5 | 6 | |
Curr. Assets | 2 | 2 | 2 | 9 | 9 | 9 | 9 | 11 | 6 | 6 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 6 | 6 | 11 | 10 | 10 | 11 | 11 | 11 | 11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | |||||||||||
Other Income | 0 | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Income | 0 | 1 | 0 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 5 | 1 | 0 | 1 | 0 | 0 | 0 | |
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | |||||||
Taxation | 0 | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 0 | |
Adjusted EPS | 2 | 2 | 1 | 31 | 1 | 1 | 3 | 2 | 4 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 6 | -2 | -5 | 5 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | |
Cash Fr. Finan. | -1 | 1 | 2 | -2 | |||||||
Net Change | 0 | 0 | 0 | 0 | 6 | 1 | -5 | 6 | 1 | -1 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 7 | 8 | 3 | 9 | 2 | 1 |
Wed, 01 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of the newspaper advertisement pertaining to financial results of the Company for the quarter and nine months ended December 31 2022. |
Tue, 31 Jan 2023
Outcome Of Board Meeting Held On Tuesday January 31 2023 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. January 31 2023 approved the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2022 along with the Limited Review Report thereon. |
Tue, 31 Jan 2023
Board Meeting Outcome for Un-Audited Financial Results Held On Tuesday January 31 2023 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. January 31 2023 approved the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2022 along with the Limited Review Report thereon. |
Tue, 07 Feb 2023 |
|
|
|
|
|